RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MESSINA M
Collezione ASL Cuneo 2

Items : 11

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Mar 10;42(8):881-885. doi: 10.1200/JCO.23.01075. Epub 2023 Dec 21.

2024
ASL Cuneo 2

Foà R; Bassan R; Elia L; Piciocchi A; Soddu S; Messina M; Ferrara F; Lunghi M; Mulè A; Bonifacio M; Fracchiolla N; Salutari P; Fazi P; Guarini A; Rambaldi A; Chiaretti S;

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2.

2024
ASL Cuneo 2
AO Ordine Mauriziano

Rescigno P; Fornarini G; Buti S; Rebuzzi SE; Vignani F; Cavo A; Signori A; Banna GL; Tudini M; Malgeri A; Nole F; Prati G; Morelli F; Messina M; Di Napoli M; Atzori F; Prati V; Soraru M; Panni S; Mollica V; Pipitone S; Ricotta R; Fratino L; Catalano F; Milella M; Procopio G; Naglieri E; Masini C; Zucal PA; et alii...

Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab. in Immunotherapy / Immunotherapy. 2024 Aug 19:1-9. doi: 10.1080/1750743X.2024.2385881.

2024
ASL Cuneo 2
AO Ordine Mauriziano

Murianni V; Rescigno P; Banna GL; Fornarini G; Buti S; Nolè F; Catalano F; Prati G; Morelli F; Messina M; Atzori F; Tudini M; Prati V; Cavo A; Roviello G; Vignani F; Caffo O; Napoli MD; Malgeri A; Rebuzzi SE; Signori A; Damassi A; Cremante M;

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study. in Journal of translational medicine / J Transl Med. 2022 Sep 30;20(1):435. doi: 10.1186/s12967-022-03601-6.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Roviello G; Rescigno P; Cavo A; Atzori F; Di Napoli M; Caffo O; Messina M; Morelli F; Prati G; Nolè F; Vignani F; Santini D; Cortellini A; Prati V; Soto Parra HJ; Mollica V; Sorarù M; Santoni M; Panni S; Ricotta R; Pipitone S; Fratino L; Buti S; Procopio G; Milella M; Boccardo F; Fantinel E; Naglieri E; Galli L; et alii...

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The ?-Meet-URO analysis. in Frontiers in oncology / Front Oncol. 2022 Sep 23;12:955501. doi: 10.3389/fonc.2022.955501. eCollection 2022.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Buti S; Fornarini G; Banna GL; Porta C; Llaja Obispo MA; Roviello G; Cavo A; Vignani F; Nolè F; Caffo O; Messina M; Morelli F; Prati G; Soto Parra HJ; Atzori F; Di Napoli M; Santoni M; Cortellini A; Prati V; Massari F; Sorarù M; Panni S; Fratino L; Sabbatini R; Ricotta R; Boccardo F; Milella M; Procopio G; Zucali PA; et alii...

2022
ASL Cuneo 2

Rebuzzi SE; Signori A; Stellato M; Santini D; Maruzzo M; De Giorgi U; Pedrazzoli P; Galli L; Zucali PA; Fantinel E; Carella C; Procopio G; Milella M; Boccardo F; Fratino L; Sabbatini R; Ricotta R; Panni S; Massari F; Sorarù M; Santoni M; Cortellini A; Prati V; Soto Parra H; Atzori F; Di Napoli M; Caffo O; Messina M; Morelli F; et alii...

The prognostic role of nephrectomy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with immunotherapy according to the novel prognostic Meet-URO score: Subanalysis of the Meet-URO 15 study in Journal of Clinical Oncology

2022
ASL Cuneo 2

Rebuzzi SE; Signori A; Banna GLL; Buti S; Rescigno P; Gemelli M; Panni S; Massari F; Sorarù M; Santoni M; Cortellini A; Prati V; Parra HJS; Atzori F; Di Napoli M; Caffo O; Messina M; Morelli F; Prati G; Fornarini G;

2022
ASL Cuneo 2

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20

2021
AO Ordine Mauriziano
ASL Cuneo 2

Buti S; Porta C; Perrino M; Brunelli M; Iacovelli R; Paolieri F; Chiellino S; Bersanelli M; Casadei C; Cavo A; Roviello G; Pierantoni F; Prati G; Vignani F; Nolè F; Morelli F; Messina M; Pignata S; Messina C; Stellato M; Atzori F; Soto Parra HJ; Cortellini A; Prati V; Sorarù M; Santoni M; Mollica V; Panni S; Fratino L; et alii...

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001154. doi: 10.1136/jitc-2020-001154.

2020
ASL Cuneo 2

Zivi A; Zampiva I; Zacchi F; von Arx C; Vivaldi C; Ventriglia J; Vitale MG; Vitiello F; Vari S; Trojanello C; Vanella V; Tomei F; Vincenzo T; Trapani D; Taveggia P; Tarantino P; Spada M; Silvestri A; Simeone E; Sbrana A; Santabarbara G; Ascierto PA; Salati M; Rossi A; Russo A; Rosanova M; Riccio V; Piccin L; Pignata S; et alii...

Baseline and early change of systemic inflammation index (bSII and ?SII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study in Journal of Clinical Oncology

2020
ASL Cuneo 2

Fornarini G; Procopio G; Signori A; Fantinel E; Zucali PA; Paolieri F; Bersanelli M; De Giorgi U; Bimbatti D; Prati V; Roviello G; Soto Parra HJ; Cavo A; Vignani F; Chiellino S; Messina M; Stellato M; Di Napoli M; Atzori F; Rebuzzi SE;